We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+13.54%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$337B
AUM Growth
+$26B
(+8.4%)
Cap. Flow
-$5.42B
Cap. Flow
% of AUM
-1.61%
Top 10 Holdings %
Top 10 Hldgs %
27.87%
Holding
3,347
New
34
Increased
1,112
Reduced
1,460
Closed
69
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Flutter Entertainment
FLUT
|
+$489M |
| 2 |
PTC
PTC
|
+$354M |
| 3 |
Citigroup
C
|
+$286M |
| 4 |
Progressive
PGR
|
+$259M |
| 5 |
Salesforce
CRM
|
+$243M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synopsys
SNPS
|
+$574M |
| 2 |
Apple
AAPL
|
+$574M |
| 3 |
Tesla
TSLA
|
+$519M |
| 4 |
Palo Alto Networks
PANW
|
+$488M |
| 5 |
EOG Resources
EOG
|
+$333M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.2% |
| 2 | Financials | 12.48% |
| 3 | Healthcare | 11.5% |
| 4 | Consumer Discretionary | 11.02% |
| 5 | Industrials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2151
Treace Medical Concepts
TMCI
$262M
| $3.18M | ﹤0.01% |
243,305
+71,880
| +42% | +$958K |
|
2152
Pliant Therapeutics
PLRX
$65M
| $3.16M | ﹤0.01% |
211,930
+21,194
| +11% | +$350K |
|
2153
Monro
MNRO
$414M
| $3.15M | ﹤0.01% |
99,857
+12,197
| +14% | +$377K |
|
2154
Ligand Pharmaceuticals
LGND
$5.77B
| $3.15M | ﹤0.01% |
43,037
| – | – |
|
2155
PRA Group
PRAA
$672M
| $3.14M | ﹤0.01% |
120,357
-191,253
| -61% | -$4.66M |
|
|
STEL
2156
DELISTED
Stellar Bancorp
STEL
| $3.13M | ﹤0.01% |
128,433
-87,283
| -40% | -$2.17M |
|
|
KE
2157
Kimball Electronics
KE
$564M
| $3.13M | ﹤0.01% |
144,507
-33,146
| -19% | -$749K |
|
2158
Biglari Holdings Class B
BH
$1.2B
| $3.13M | ﹤0.01% |
16,488
+231
| +1% | +$39K |
|
2159
Embecta
EMBC
$218M
| $3.13M | ﹤0.01% |
235,505
-1,422
| -0.6% | -$22K |
|
|
GES
2160
DELISTED
Guess Inc
GES
| $3.12M | ﹤0.01% |
99,261
| – | – |
|
2161
S&T Bancorp
STBA
$1.9B
| $3.12M | ﹤0.01% |
97,212
-3,137
| -3% | -$101K |
|
|
HIBB
2162
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $3.1M | ﹤0.01% |
40,318
-1,511
| -4% | -$108K |
|
|
THR
2163
DELISTED
Thermon Group Holdings
THR
| $3.08M | ﹤0.01% |
94,222
-264,979
| -74% | -$7.78M |
|
2164
Rocket Lab Corp
RKLB
$36.6B
| $3.08M | ﹤0.01% |
749,452
| – | – |
|
2165
Sally Beauty Holdings
SBH
$1.47B
| $3.07M | ﹤0.01% |
247,463
| – | – |
|
2166
Rayonier Advanced Materials
RYAM
$562M
| $3.07M | ﹤0.01% |
642,511
-213,705
| -25% | -$909K |
|
|
GLDD
2167
DELISTED
Great Lakes Dredge & Dock
GLDD
| $3.07M | ﹤0.01% |
350,945
-123,605
| -26% | -$1.02M |
|
|
ETWO
2168
DELISTED
E2open Parent Holdings
ETWO
| $3.06M | ﹤0.01% |
689,453
+30,477
| +5% | +$123K |
|
2169
IES Holdings
IESC
$9.89B
| $3.05M | ﹤0.01% |
25,059
-1,093
| -4% | -$105K |
|
2170
Orthofix Medical
OFIX
$492M
| $3.05M | ﹤0.01% |
209,817
-53,476
| -20% | -$739K |
|
2171
Universal Insurance Holdings
UVE
$1.26B
| $3.05M | ﹤0.01% |
149,912
+57,760
| +63% | +$1.04M |
|
|
SPTN
2172
DELISTED
SpartanNash
SPTN
| $3.04M | ﹤0.01% |
150,526
-108,399
| -42% | -$2.34M |
|
2173
Adeia
ADEA
$2.55B
| $3.04M | ﹤0.01% |
278,265
-8,449
| -3% | -$98.6K |
|
2174
Heron Therapeutics
HRTX
$93.4M
| $3.03M | ﹤0.01% |
1,094,687
+1,002,935
| +1,093% | +$2.52M |
|
|
PBPB
2175
DELISTED
Potbelly
PBPB
| $3.03M | ﹤0.01% |
250,124
+36,090
| +17% | +$452K |
|
Similar funds
VFT
Nuveen's Q1 2024 Portfolio in Review
As of Q1 2024, Nuveen held 3,347 positions worth $337B, up 8.4% from $311B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3.1%. Nuveen opened 34 new positions and exited 69, leaving the 3,347-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
- Nuveen's largest Q1 2024 buy was Flutter Entertainment: 2,293,926 shares worth $458M.
- Nuveen added most to PTC in Q1 2024, an estimated $354M increase.
- Nuveen's biggest Q1 2024 reduction was Synopsys, cutting an estimated $574M.
- Nuveen fully exited Splunk Inc in Q1 2024, selling an estimated $159M.
- Nuveen's ten largest holdings make up 28% of its $337B portfolio in Q1 2024.
- Nuveen opened 34 new positions and closed 69 in Q1 2024.
- Nuveen's portfolio value rose 8.4% quarter-over-quarter to $337B.
Based on Nuveen's 13F filing for Q1 2024, filed 13 May 2024.